Bio-Rad Laboratories, Inc. SEC filings BIO
Bio-Rad Laboratories, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 1, 2011. Its latest annual report, Form ARS, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Apr 30, 2026 | — |
| S-8 | Employee stock plan registration | May 8, 2024 | — |
| 424B2 | Prospectus | Feb 25, 2022 | — |
| FWP | Free writing prospectus | Feb 24, 2022 | — |
| 424B5 | Prospectus supplement | Feb 23, 2022 | — |
| S-3ASR | Automatic shelf registration | Feb 15, 2022 | — |
| S-8 | Employee stock plan registration | Aug 29, 2017 | — |
| S-8 POS | Filing | Sep 11, 2015 | — |
| S-8 | Employee stock plan registration | Sep 11, 2015 | — |
| S-8 | Employee stock plan registration | Aug 8, 2014 | — |
| S-8 | Employee stock plan registration | Mar 2, 2012 | — |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- BIO (NYSE), BIO-B (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hercules, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 12208
- Former names
- BIO RAD LABORATORIES INC (until Jun 18, 2018)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Source: SEC EDGAR filings. This is company-reported data, not investment advice.